tiprankstipranks
Trending News
More News >
Kalaris Therapeutics (KLRS)
NASDAQ:KLRS
US Market
Advertisement

Kalaris Therapeutics (KLRS) Technical Analysis

Compare
358 Followers

Technical Sentiment

Overall Consensus
Sell
6Bullish
4Neutral
12Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Strong Sell
2Bullish
0Neutral
10Bearish
Kalaris Therapeutics’s (KLRS) Moving Averages Convergence Divergence (MACD) indicator is 0.11, suggesting Kalaris Therapeutics is a Buy.
Kalaris Therapeutics’s (KLRS) 20-Day exponential moving average is 5.25, while Kalaris Therapeutics’s (KLRS) share price is $4.63, making it a Sell.
Kalaris Therapeutics’s (KLRS) 50-Day exponential moving average is 4.66, while Kalaris Therapeutics’s (KLRS) share price is $4.63, making it a Sell.

Kalaris Therapeutics (KLRS) Pivot Points

Oct 21, 2025, 06:51 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
4.42
4.58
4.68
4.84
4.95
5.11
5.21
Fibonacci
4.58
4.68
4.74
4.84
4.94
5.01
5.11
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Kalaris Therapeutics (KLRS) Moving Averages

Oct 21, 2025, 06:51 AM
Period
Simple
Exponential
MA5
4.84Sell
4.89Sell
MA10
5.56Sell
5.20Sell
MA20
5.58Sell
5.25Sell
MA50
4.34Buy
4.66Sell
MA100
3.51Buy
4.65Sell
MA200
5.82Sell
6.79Sell
Kalaris Therapeutics’s (KLRS) 10-Day exponential moving average is 5.20, while Kalaris Therapeutics’s (KLRS) share price is $4.63, making it a Sell.
Kalaris Therapeutics’s (KLRS) 100-Day exponential moving average is 4.65, while Kalaris Therapeutics’s (KLRS) share price is $4.63, making it a Sell.
Kalaris Therapeutics’s (KLRS) stock price is $4.63 and Kalaris Therapeutics’s (KLRS) 50-day simple moving average is 4.34, creating a Buy signal.
Kalaris Therapeutics’s (KLRS) stock price is $4.63 and Kalaris Therapeutics’s (KLRS) 100-day simple moving average is 3.51, creating a Buy signal.
Kalaris Therapeutics’s (KLRS) stock price is $4.63 and Kalaris Therapeutics’s (KLRS) 200-day simple moving average is 5.82, creating a Sell signal.

Kalaris Therapeutics (KLRS) Technical Indicators

Oct 21, 2025, 06:51 AM
Name
Value
Implied Action
RSI (14)
45.94
Neutral
STOCH (9,6)
11.14
Buy
STOCHRSI (14)
10.93
Buy
MACD (12,26)
0.11
Buy
ADX (14)
44.90
Neutral
Williams %R
-92.47
Buy
CCI (14)
-65.02
Neutral
ATR (14)
0.84
-
Ultimate Oscillator
34.56
Neutral
ROC
-27.09
Sell
Kalaris Therapeutics’s (KLRS) Relative Strength Index (RSI) is 45.94, creating a Neutral signal.
Kalaris Therapeutics’s (KLRS) Trend Strength Indicator (ADX) is 44.90, creating a Neutral signal.
Kalaris Therapeutics’s (KLRS) Commodity Channel Index (CCI) is -65.02, creating a Neutral signal.
Kalaris Therapeutics’s (KLRS) Price Rate of Change (ROC) is -27.09, creating a Sell signal.

FAQ

Is KLRS a Buy, Hold, or Sell?
Based on KLRS’s technical indicators, KLRS is a Sell.
    What is KLRS’s RSI (14)?
    KLRS’s RSI (14) is 45.94, which suggests KLRS is a Neutral.
      What is KLRS’s MACD?
      KLRS’s MACD is 0.11, which suggests KLRS is a Buy.
        What is KLRS’s 5-day moving average?
        KLRS’s 5-day moving average is 4.84, which suggests KLRS is a Sell.
          What is KLRS’s 20-day moving average?
          KLRS 20-day moving average is 5.58, which suggests KLRS is a Sell.
            What is KLRS’s 50-day moving average?
            KLRS’s 50-day moving average is 4.34, which suggests KLRS is a Buy.
              What is KLRS’s 200-day moving average?
              KLRS’s 200-day moving average is 5.82, which suggests KLRS is a Sell.
                What is KLRS’s Williams % R (14)?
                KLRS’s Williams % R (14) is -92.47, which suggests KLRS is a Buy.
                  What is KLRS’s CCI (14)?
                  KLRS’s CCI (14) is -65.02, which suggests KLRS is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis